Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003637013 | SCV004406440 | pathogenic | MHC class II deficiency | 2022-10-19 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with RFX5-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp58Thrfs*27) in the RFX5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RFX5 are known to be pathogenic (PMID: 7744245, 9401005, 10079298). |